Canada Blood-based Biomaker For Sports Medicine Market Size & Outlook

The blood-based biomaker for sports medicine market in Canada is expected to reach a projected revenue of US$ 60.8 million by 2030. A compound annual growth rate of 8.3% is expected of Canada blood-based biomaker for sports medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$34.8
Forecast, 2030 (US$M)
$60.8
CAGR, 2024 - 2030
8.3%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada blood-based biomaker for sports medicine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Canada blood-based biomaker for sports medicine market highlights

  • The Canada blood-based biomaker for sports medicine market generated a revenue of USD 34.8 million in 2023 and is expected to reach USD 60.8 million by 2030.
  • The Canada market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, ck was the largest revenue generating type in 2023.
  • CRP is the most lucrative type segment registering the fastest growth during the forecast period.


Blood-based biomaker for sports medicine market data book summary

Market revenue in 2023USD 34.8 million
Market revenue in 2030USD 60.8 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentCk
Fastest growing segmentCRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6


Other key industry trends

  • In terms of revenue, Canada accounted for 5.2% of the global blood-based biomaker for sports medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 425.8 million by 2030.

Ck was the largest segment with a revenue share of 18.1% in 2023. Horizon Databook has segmented the Canada blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.


The high prevalence of sports injuries in Canada, driven by widespread participation in hockey, soccer, and skiing, is expected to fuel the market growth for blood-based biomarkers in sports medicine. According to a report published in Scholastica in December 2022, over 10 years of competition, around 3,160 injuries were reported among 8,710 male athletes, and 3,272 injuries were reported among 8,391 female athletes.

The injury incidence rates were 362.8 per 1,000 male athletes and 389.9 per 1,000 female athletes. Female athletes were found to have 1.12 times higher odds of injury and 1.37 times higher odds of illness compared to their male counterparts.

As more Canadians engage in sports, the need for advanced tools to diagnose, manage, and prevent injuries has become increasingly critical. Blood-based biomarkers offer a noninvasive way to detect early signs of injuries, such as concussions and muscle damage, enabling quicker & more accurate interventions.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood-based Biomaker for Sports Medicine Market Companies

Name Profile # Employees HQ Website
RayBiotech View profile 101-250 Norcross, Georgia, United States, North America http://www.raybiotech.com/
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
Beckman Coulter View profile 10001+ Brea, California, United States, North America http://www.beckmancoulter.com
ARUP Laboratories View profile 1001-5000 Salt Lake City, Utah, United States, North America http://www.aruplab.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Canada blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

Canada Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)

Canada blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online